The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol

References

• Wang M, Zhang J, Yuan Z, et al. Targeted thrombolysis by using of magnetic mesoporous silica nanoparticles. J Biomed Nanotech 2012;8:624–32
   PubMed Web of Science ®Google Scholar
• Kim JH, Burnett RD, Gabriel A. Stimuli-responsive hollow polymer nanoparticles for use as novel delivery systems. J Biomed Nanotech 2012;8:432–8
   PubMed Web of Science ®Google Scholar
• Wu C, Wang Z, Zhi Z, et al. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs. Int J Pharm 2011;403:162–9
   PubMed Web of Science ®Google Scholar
• Arruebo M. Drug delivery from structured porous inorganic materials. Wiley Interdisciplinary Rev Nanomed Nanobiotechnol 2012;4:16–30
   PubMed Web of Science ®Google Scholar
• Klichko Y, Liong M, Choi E, et al. Mesostructured silica for optical functionality, nanomachines, and drug delivery. J Am Chem Soc 2009;92:S2–10
   Web of Science ®Google Scholar
• Zhao Q, Wang T, Wang J, et al. Template-directed hydrothermal synthesis of hydroxyapatite as a drug delivery system for the poorly water-soluble drug carvedilol. Appl Surf Sci 2011;257:10126–33
   Web of Science ®Google Scholar
• Izquierdo-Barba I, Sousa E, Doadrio JC, et al. Influence of mesoporous structure type on the controlled delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-15. J Sol-Gel Sci Technol 2009;50:421–9
   Web of Science ®Google Scholar
• Ukmar T, Planinšek O. Ordered mesoporous silicates as matrices for controlled release of drugs. Acta Pharmaceut 2010;60:373–85
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhi Z, Zhao Q, et al. 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol. Micropor Mesopor Mat 2011;147:94–101
   Web of Science ®Google Scholar
• Zhao P, Wang L, Sun C, et al. Uniform mesoporous carbon as a carrier for poorly water soluble drug and its cytotoxicity study. Eur J Pharm Biopharm 2011;80:535–43
   PubMed Web of Science ®Google Scholar
• Jiang H, Wang T, Wang L, et al. Development of an amorphous mesoporous TiO2 nanosphere as a novel carrier for poorly water-soluble drugs: effect of different crystal forms of TiO2 carriers on drug loading and release behaviors. Micropor Mesopor Mat 2012;153:124--30
   Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. Nanosizing – oral formulation development and biopharmaceutical evaluation. Adv Drug Deliver Rev 2007;59:631–44
   PubMed Web of Science ®Google Scholar
• Slowing II, Vivero-Escoto JL, Wu C-W, Lin VS-Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliver Rev 2008;60:1278–88
   PubMed Web of Science ®Google Scholar
• Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Edit 2007;46:7548–58
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang J, Zhi Z, et al. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. J Colloid Interf Sci 2011;363:410–17
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhi Z, Jiang T, et al. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release 2010;145:257–63
   PubMed Web of Science ®Google Scholar
• Kresge C, Leonowicz M, Roth W, et al. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992;359:710–12
   Web of Science ®Google Scholar
• Alfredsson V, Anderson MW. Structure of MCM-48 revealed by transmission electron microscopy. Chem Mater 1996;8:1141–6
   Web of Science ®Google Scholar
• Munoz B, Ramila A, Perez-Pariente J, et al. MCM-41 organic modification as drug delivery rate regulator. Chem Mater 2003;15:500–3
   Web of Science ®Google Scholar
• Manzano M, Aina V, Arean C, et al. Studies on MCM-41 mesoporous silica for drug delivery: effect of particle morphology and amine functionalization. Chem Eng J 2008;137:30–7
   Web of Science ®Google Scholar
• Nazzal S, Guven N, Reddy IK, Khan MA. Preparation and characterization of Coenzyme Q10-Eudragit® solid dispersion. Drug Dev Ind Pharm 2002;28:49–57
   PubMed Web of Science ®Google Scholar
• Jang HT, Park YK, Ko YS, et al. Highly siliceous MCM-48 from rice husk ash for CO2 adsorption. J Greenh Gas Con 2009;3:545–9
   Web of Science ®Google Scholar
• Benhamou A, Baudu M, Derriche Z, Basly JP. Aqueous heavy metals removal on amine-functionalized Si-MCM-41 and Si-MCM-48. J Hazard Mater 2009;171:1001–8
   PubMed Web of Science ®Google Scholar
• Halamová D, Zeleňák V. NSAID naproxen in mesoporous matrix MCM-41: drug uptake and release properties. J Incl Phenom Macro 2012;72:15–23
   Web of Science ®Google Scholar
• Kawabata Y, Wada K, Nakatani M, et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 2011;420:1–10
   PubMed Web of Science ®Google Scholar
• Schumacher K, Grün M, Unger K. Novel synthesis of spherical MCM-48. Micropor Mesopor Mat 1999;27:201–6
   Web of Science ®Google Scholar
• Suteewong T, Sai H, Cohen R, et al. Highly Aminated Mesoporous Silica Nanoparticles with Cubic Pore Structure. J Am Chem Soc 2011;133:172–5
   PubMed Web of Science ®Google Scholar
• Krahn CL, Raffin RP, Santos GS, et al. Isoflurane-loaded nanoemulsion prepared by high-pressure homogenization: investigation of stability and dose reduction in general anesthesia. J Biomed Nanotechnol 2012;8:849–58
   PubMed Web of Science ®Google Scholar
• Limnell T, Santos HA, Mäkilä E, et al. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. J Pharm Sci 2011;100:3294–306
   PubMed Web of Science ®Google Scholar
• Jiang T, Wu C, Gao Y, et al. Preparation of novel porous starch microsphere foam for loading and release of poorly water soluble drug. Drug Dev Ind Pharm 2013 . [Epub ahead of print]. doi:10.3109/03639045.2012.756511
   Web of Science ®Google Scholar
• Miao X, Sun C, Jiang T, et al. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol. J Pharm Pharm Sci 2011;14:196–214
   PubMed Web of Science ®Google Scholar
• Yang X, Liu R, Dong Y. Research Paper Regulative effects of ovarian steroids on rat gastric motility and sensitivity. Acta Physiologica Sinica 2006;58:275–80
   PubMedGoogle Scholar
• Meynen V, Cool P, Vansant E. Verified syntheses of mesoporous materials. Micropor Mesopor Mat 2009;125:170–223
   Web of Science ®Google Scholar
• Sun L, Wang Y, Jiang T, et al. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol. ACS Appl Mater Inter 2013;5:103–13
   PubMed Web of Science ®Google Scholar
• Everett D, Haul R, Moscou L, et al. Reporting physisorption data for gas solid systems with special reference to the determination of surface-area and porosity. Pure Appl Chem 1985;57:603--19
   Web of Science ®Google Scholar
• Kailasam K, Fels A, Müller K. Octadecyl grafted MCM-41 silica spheres using trifunctionalsilane precursors–preparation and characterization. Micropor Mesopor Mat 2009;117:136–47
   Web of Science ®Google Scholar
• Romero AA, Alba MD, Zhou W, Klinowski J. Synthesis and characterization of the mesoporous silicate molecular sieve MCM-48. J Phys Chem B 1997;101:5294–300
   Web of Science ®Google Scholar
• Schumacher K, Ravikovitch PI, Du Chesne A. Characterization of MCM-48 materials. Langmuir 2000;16:4648–54
   Web of Science ®Google Scholar
• Qian KK, Bogner RH. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. J Pharm Sci 2012;101:444–63
   PubMed Web of Science ®Google Scholar
• Stowell GW, Behme RJ, Denton SM, et al. Thermally-prepared polymorphic forms of cilostazol. J Pharm Sci 2002;91:2481–8
   PubMed Web of Science ®Google Scholar
• Blagden N, De Matas M, Gavan P, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 2007;59:617–30
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60
   PubMed Web of Science ®Google Scholar
• Najib N, Suleiman M. The kinetics of drug release from ethylcellulose solid dispersions. Drug Dev Ind Pharm 1985;11:2169–81
   Web of Science ®Google Scholar
• Iqbal Z, Babar A, Ashraf M. Controlled-release naproxen using micronized ethyl cellulose by wet-granulation and solid-dispersion method. Drug Dev Ind Pharm 2002;28:129–34
   PubMed Web of Science ®Google Scholar
• Pan R-N, Chen J-H, Chen RR-L. Enhancement of dissolution and bioavailability of piroxicam in solid dispersion systems. Drug Dev Ind Pharm 2000;26:989–94
   PubMed Web of Science ®Google Scholar
• Jinno J, Kamada N, Miyake M, et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release 2006;111:56–64
   PubMed Web of Science ®Google Scholar
• O'driscoll C, Griffin B. Biopharmaceutical challenges associated with drugs with low aqueous solubility – the potential impact of lipid-based formulations. Adv Drug Deliver Rev 2008;60:617–24
   PubMed Web of Science ®Google Scholar
• Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930–4
   Google Scholar
• Jinno J, Kamada N, Miyake M, et al. In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. J Control Release 2008;130:29–37
   PubMed Web of Science ®Google Scholar
• Li X, Gu L, Xu Y, Wang Y. Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats. Drug Dev Ind Pharm 2009;35:827–33
   PubMed Web of Science ®Google Scholar
• Emara L, Badr R, Abd Elbary A. Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers. Drug Dev Ind Pharm 2002;28:795–807
   PubMed Web of Science ®Google Scholar